AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8582916
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment with silver sulfadiazine
Trial: 2669473
Drug: Prazosin GITS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin GITS (Minipress XL) 10 mg
Trial: 2669473
Drug: Prazosin GITS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin GITS (Minipress XL) 20 mg
Trial: 2669473
Drug: Prazosin GITS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin GITS (Minipress XL) (10, 20 mg)
Trial: 28625383
Drug: Single antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single antiplatelet therapy or no therapy (control)
Trial: 17296463
Drug: Ofloxacin ER
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin ER 400 mg QD
Trial: 17296463
Drug: Ofloxacin IR
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin IR 200 mg BID
Trial: 14625264
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of alcohol per day
Trial: 14625264
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of alcohol per day
Trial: 7818063
Drug: Vecuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium administered by the Springfusor infusion device
Trial: 7818063
Drug: Vecuronium by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium by intermittent bolus injection
Trial: 3247518
Drug: Ketotifen (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen (two 1‐mg capsules)
Trial: 31288778
Drug: Pelvic plexus
RxNorm normalized name: Bos taurus solar plexus preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic plexus block (PPB) with 5 ml of 1% lidocaine
Trial: 31288778
Drug: Conventional periprostatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional periprostatic nerve block (PNB) with 5 ml of 1% lidocaine
Trial: 31288778
Drug: Prostate capsule
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate capsule local anesthesia with 22 ml of 1% lidocaine (Control group)
Trial: 26425886
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (E2) for 1 week
Trial: 22044856
Drug: Therapeutic drug
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic drug monitoring (TDM) with PI dose escalation
Trial: 15306005
Drug: Fast rectal
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast rectal distension at 100 mL min(‐1)
Trial: 15306005
Drug: Slow rectal
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow rectal distension at 10 mL min(‐1)
Trial: 11296014
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of brimonidine and timolol
Trial: 9032494
Drug: Ketotifen, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen, 2 mg.day‐1
Trial: 30354703
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing of antihypertensive agents
Trial: 30354703
Drug: Evening dosing
RxNorm normalized name: Evening Dosing 24 HR Jornay 60 MG Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dosing of antihypertensive agents
Trial: 29944706
Drug: Daily self-weighing
RxNorm normalized name: DAILY SELF DISCOVERY SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily self-weighing (DSW)
Trial: 8810613
Drug: Manual titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual titration
Trial: 18650127
Drug: Automatic titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic titration
Trial: 15588342
Drug: Indinavir and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir and efavirenz combination therapy
Trial: 7888703
Drug: Anal submucosal
RxNorm normalized name: Mephitis mephitis anal gland fluid preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anal submucosal injection of methotrexate (MXT) 50 mg
Trial: 7888703
Drug: Parenteral injection
RxNorm normalized name: WATER 1 mL in 1 mL PARENTERAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral injection of methotrexate (MXT) 50 mg
Trial: 3209832
Drug: Intracervical PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracervical PGE2 gel application
Trial: 27702806
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel application
Trial: 18326610
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Fe + 400 microg folate
Trial: 9245683
Drug: Cognitive-behavioral smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral smoking cessation treatment plus vigorous exercise
Trial: 12649057
Drug: Cognitive-behavioral smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral smoking cessation treatment plus contact control
Trial: 8438811
Drug: ADTP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADTP vaccine
Trial: 8438811
Drug: WDTP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WDTP vaccine
Trial: 2574594
Drug: Terfenadine 120
RxNorm normalized name: terfenadine 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 120 mg twice daily
Trial: 24355952
Drug: Probiotic ice-cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic ice-cream (100 ml)
Trial: 24355952
Drug: Probiotic curd
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic curd (100 ml)
Trial: 24355952
Drug: Plain ice-cream
RxNorm normalized name: clioquinol Topical Cream [Iodo Plain]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain ice-cream (100 ml)
Trial: 24355952
Drug: Plain curd
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain curd (100 ml)
Trial: 22164745
Drug: ISMN 40
RxNorm normalized name: ISMN
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ISMN 40 mg
Trial: 22164745
Drug: ISMN ‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISMN ‐ SR 60 mg
Trial: 22164745
Drug: Placebo Vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Vitamin C 100 mg
Trial: 22164745
Drug: ISMN groups
RxNorm normalized name: ISMN
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ISMN groups (both ISMN 40 mg and ISMN ‐ SR 60 mg)
Trial: 15656713
Drug: Krill oil
RxNorm normalized name: Krill oil
DrugBank: Krill oil (DB16615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill oil 1-3 g per day (BMI-dependent)
Trial: 15656713
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3 g daily containing 180 mg EPA and 120 mg DHA)
Trial: 9140154
Drug: Omeprazole (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (80 mg + mg/h) continuous infusion for 72 hours
Trial: 22653986
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (0.3 mg) in exercise group (EX)
Trial: 22653986
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (0.3 mg) in control group (CON)
Trial: 22653986
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (0.3 mg) in both groups
Trial: 7854929
Drug: IMED 980
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMED 980 infusion pump
Trial: 7854929
Drug: Gemini infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemini infusion pump
Trial: 1008239
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg of 1,8% dextran in lactated Ringer's solution
Trial: 1008239
Drug: Enflurane anaesthesia
RxNorm normalized name: Enflurane
DrugBank: Enflurane (DB00228)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enflurane anaesthesia with preanaesthetic volume administration
Trial: 28247675
Drug: Vitaprost forte
RxNorm normalized name: Erythroped Forte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitaprost forte (rectal suppositories) and Vitaprost tablets
Trial: 28247675
Drug: Standard anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard anti-inflammatory therapy
Trial: 28247675
Drug: Vitaprost treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitaprost treatment
Trial: 23188563
Drug: Minilaparoscopic (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minilaparoscopic (ML) Cholecystectomy
Trial: 9116434
Drug: NaHCO3 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaHCO3 therapy (2 mmol/kg/day for 7 days)
Trial: 9116434
Drug: NaCl therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl therapy (2 mmol/kg/day for 7 days)
Trial: 7506150
Drug: Paracetamol 500mg
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol 500mg
Trial: 2411246
Drug: Zimeldine (individualized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimeldine (individualized doses to achieve plasma concentrations of 50 to 100 ng/mL)
Trial: 30236237
Drug: Sugammadex 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 4 mg kg-1
Trial: 30236237
Drug: Sugammadex 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 16 mg kg-1
Trial: 26754331
Drug: AndroForte 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AndroForte 5 testosterone cream
Trial: 26754331
Drug: Testogel 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testogel 1% testosterone gel
Trial: 9796053
Drug: DTPa-HBV/Hib vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa-HBV/Hib vaccines co-administered with oral polio vaccine
Trial: 7637191
Drug: Vecuronium (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.03 mg.kg‐1)
Trial: 7637191
Drug: Vecuronium (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.03 mg.kg‐1) after succinylcholine (1.0 mg.kg‐1)
Trial: 7637191
Drug: Succinylcholine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine (1.0 mg.kg‐1) followed by vecuronium (0.03 mg.kg‐1)
Trial: 2793383
Drug: Acivicin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acivicin (60 mg/m2/course, administered as a 72‐hr infusion)
Trial: 2793383
Drug: Vinblastine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinblastine (7.5 mg/m2/course, administered as a 120‐hr infusion)
Trial: 350473
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg aspirin and 64 mg caffeine (aspirin-caffeine)
Trial: 24102344
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus iloprost (administered for 10 days every 3 months)
Trial: 24102344
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy (Control Group A)
Trial: 24102344
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus iloprost
Trial: 20498326
Drug: RDEA806 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RDEA806 (400 mg twice a day)
Trial: 20498326
Drug: RDEA806 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RDEA806 (600 mg once a day)
Trial: 20498326
Drug: RDEA806 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RDEA806 (800 mg once a day)
Trial: 20498326
Drug: RDEA806 (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RDEA806 (1,000 mg once a day)
Trial: 16552549
Drug: Hamstring tendon
RxNorm normalized name: Bos taurus tendon preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hamstring tendon with titanium metal plate suspension and screw-washer postdistally
Trial: 14634404
Drug: Rectal sensation
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal sensation test used during apical biopsy
Trial: 14634404
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without rectal sensation test
Trial: 10801252
Drug: Lanepitant (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanepitant (20, 60, 200, or 600 mg initial dose, followed by 10, 30, 100, or 300 mg twice a day)
Trial: 10801252
Drug: Naproxen (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (375 mg twice a day)
Trial: 22697441
Drug: False safety
RxNorm normalized name: ALLERGENIC EXTRACT, FALSE RAGWEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: False safety behavior elimination therapy (F-SET)
Trial: 18568502
Drug: Intranasal microemulsion
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal microemulsion treatment
Trial: 15821951
Drug: LY544344 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY544344 (80 mg bid for 1 week)
Trial: 11830461
Drug: Foscarnet (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foscarnet (60 mg/kg for 2 weeks, then 90 mg/kg for 2 weeks if needed)
Trial: 11830461
Drug: Ganciclovir (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir (5 mg/kg every 12 hours for 2 weeks, then 6 mg/kg once daily for 5 days per week if needed)
Trial: 12212053
Drug: Captopril (along
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (along with antibiotics and oxygen) for 14 days
Trial: 12212053
Drug: Antibiotics and
RxNorm normalized name: Antibiotics and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics and oxygen
Trial: 2202461
Drug: Cyclosporine, 1
RxNorm normalized name: CycloSPORINE, 100 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine, 1 mg/kg daily from days 1-28 administered intravenously in four patients and orally in five.
Trial: 6988169
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g cephradine administered twice daily for 1 week
Trial: 6988169
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g cephradine administered 4-times a day
Trial: 30520252
Drug: Insulin Glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin Glargine (IG)
Trial: 18387078
Drug: Neutral Protamine
RxNorm normalized name: Neutral protamine hagedorn insulin
DrugBank: Neutral Protamine Hagedorn (NPH) insulin (DB18001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral Protamine Hagedorn (NPH) insulin
Trial: 21362084
Drug: VAC(®) Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC(®) Therapy System
Trial: 21316208
Drug: DHA (220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (220 mg/day)
Trial: 18955102
Drug: DHA+AA (220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA+AA (220 mg/day each)
Trial: 10050456
Drug: Peroral pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral pulse therapy with methylprednisolone, 1000 mg daily for three days
Trial: 10050456
Drug: Intravenous pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pulse therapy with methylprednisolone, 1000 mg daily for three days
Trial: 10050456
Drug: Peroral pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral pulse therapy with methylprednisolone
Trial: 8065284
Drug: Flurbiprofen 100
RxNorm normalized name: flurbiprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 100 mg tablet, twice daily
Trial: 8065284
Drug: Flurbiprofen mouthwash
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen mouthwash 10 ml (0.25%), rinsed 6 times daily for three minutes
Trial: 3385024
Drug: 2% minoxidil
RxNorm normalized name: MINOXIDIL 2 g in 100 mL TOPICAL LIQUID [2% Minoxidil hair growth serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% minoxidil gel
Trial: 22993340
Drug: Exemestane therapy
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exemestane therapy for 30 months
Trial: 22993340
Drug: Analgesics use
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesics use
Trial: 17715042
Drug: Azithromycin tablet
RxNorm normalized name: Azithromycin Tablets
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin tablet (500 mg) from pharmaceutical company 1
Trial: 17715042
Drug: Azithromycin tablet
RxNorm normalized name: Azithromycin Tablets
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin tablet (500 mg) from pharmaceutical company 2
Trial: 17715042
Drug: Azithromycin tablet
RxNorm normalized name: Azithromycin Tablets
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin tablet (500 mg) from pharmaceutical company 3
Trial: 10684389
Drug: Patch testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch testing
Trial: 10485389
Drug: Patch test
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch test
Trial: 8334031
Drug: Clodronate 400
RxNorm normalized name: clodronic acid 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate 400 mg daily for 30 days, followed by 60 days of no treatment (Group 2)
Trial: 8334031
Drug: Oral calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcitriol 2 mcg for 5 days and clodronate 400 mg daily for additional 25 days, followed by 60 days of no treatment (Group 3)
Trial: 30204734
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Group 1)
Trial: 26508298
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (400 µg/day)
Trial: 31352663
Drug: Nutraceutical compounds
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutraceutical compounds (red yeast rice, Berberine, Coenzyme Q10, folic acid and chrome) added to diet for 3 months
Trial: 28790226
Drug: Metformin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (3 x 500 mg)
Trial: 25999334
Drug: Treatment by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment by experienced community therapists
Trial: 24261946
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with a grass pollen tablet for 4 months
Trial: 9143001
Drug: Intranasal CRH
RxNorm normalized name: Ovine CRH
DrugBank: Corticorelin ovine triflutate (DB09067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal CRH (20 micrograms every 10 min)
Trial: 9143001
Drug: Intranasal CRH
RxNorm normalized name: Ovine CRH
DrugBank: Corticorelin ovine triflutate (DB09067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal CRH
Trial: 7802851
Drug: Alprazolam (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (5 mg daily)
Trial: 3314832
Drug: Colchicine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (mean dose 6.7 mg)
Trial: 23044285
Drug: Aripiprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (10 or 30 mg/day)
Trial: 21950194
Drug: Warfarin adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin adjusted to maintain INR between 1.5 and 1.9 (Group A)
Trial: 21950194
Drug: Warfarin adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin adjusted to maintain INR between 2 and 3 (Group B)
Trial: 9495931
Drug: Absorbable collagen
RxNorm normalized name: Absorbable collagen sponge bone graft product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Absorbable collagen membrane in guided tissue regeneration (GTR) therapy
Trial: 8454791
Drug: Skin testing
RxNorm normalized name: INVESTIGATIONAL DIAGNOSTIC AGENTS,SKIN TESTING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin testing with major and minor determinants of benzylpenicillin and minor determinant mixtures of ampicillin, amoxicillin, or cloxacillin
Trial: 8454791
Drug: Skin testing
RxNorm normalized name: INVESTIGATIONAL DIAGNOSTIC AGENTS,SKIN TESTING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin testing with semisynthetic penicillin reagents derived from ampicillin, amoxicillin, or cloxacillin
Trial: 8454791
Drug: Ampicillin and
RxNorm normalized name: Ampicillin and sulbactam only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin and amoxicillin
Trial: 3755683
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg cimetidine with 1 g sucralfate